Related by context. All words. (Click for frequent words.) 72 CIMZIA ™ 71 oral FTY# 71 KRAS mutations occur 71 relapsed MM 70 elevated ALT 69 achieved ACR# 69 HBeAg positive patients 69 tipranavir r 69 recurrent glioblastoma multiforme 68 FluCAM arm 68 AA Amyloidosis 68 PREZISTA r 68 ACTEMRA TM 68 adalimumab Humira 68 eosinophilic asthma 68 certolizumab 68 INCB# [003] 68 ARCOXIA 68 evaluable subjects 68 ARB telmisartan 68 CIMZIA TM certolizumab pegol 68 reduce serum phosphate 68 octreotide LAR 67 refractory gout 67 hyperphenylalaninemia HPA due 67 Traficet EN 67 prednisone prednisolone 67 ARCALYST ® 67 SNT-MC#/idebenone 67 placebo dexamethasone 67 diabetic neuropathic pain 66 chronic HCV infection 66 ruboxistaurin 66 Raptiva ® 66 primary Restless Legs 66 elevated triglyceride levels 66 APTIVUS r 66 efalizumab 66 phase IIb study 66 hour bronchodilation 66 EXJADE 66 acromegalic patients 66 AGILECT R 66 ximelagatran 66 clodronate 66 COPAXONE R 66 serum phosphate 66 teriflunomide 66 calcineurin inhibitor 66 metastatic GIST 66 TNF antagonist 66 CIMZIA TM 66 psoriatic arthritis PsA 66 Proleukin 66 acetonide FA 66 Teriflunomide 66 8mg/kg 66 HIV HCV coinfected 66 Bezielle 66 rimonabant #mg 66 canakinumab 66 IOP lowering 65 MCyR 65 mitoxantrone plus 65 non metastatic osteosarcoma 65 MAGE A3 ASCI 65 intravenous bisphosphonates 65 chronic idiopathic thrombocytopenic purpura 65 dose cohort 65 oral allopurinol 65 adjunctive placebo 65 leukemia AML 65 CAELYX 65 FROVA 65 CTAP# Capsules 65 BARACLUDE ® 65 NATRECOR R 65 Infusion Reactions Severe 65 CYPHER Stent 65 Dacogen decitabine 65 hepatorenal syndrome 65 GLIADEL R Wafer 65 CTEPH 65 SHPT 65 RAPTIVA 65 ACZ# 65 ORENCIA ® 65 smoldering multiple myeloma 65 acne vulgaris 65 definite stent thrombosis 65 CIPN 65 anterior uveitis 65 somatostatin analog 65 RRMS patients 65 low dose Iluvien 65 riociguat 65 ATACAND 65 PROMACTA 65 autoantibody positive 65 Eltrombopag 65 Aflibercept 65 Ophena TM 65 #mg dose [002] 65 Pemetrexed 65 YONDELIS 65 Syndrome RLS 65 Velcade bortezomib 65 ALT flares 65 dyslipidaemia 65 oxycodone CR 65 Kepivance 65 RhuDex ® 65 comorbid ADHD 65 forodesine 65 Crohn disease CD 65 recurrent genital herpes 65 Vidaza azacitidine 65 FOLFOX4 65 severe exacerbations 65 colorectal liver metastases 65 CANCIDAS 65 neutropenia dehydration dyspnea 64 vismodegib 64 non splenectomized 64 corticosteroid dose 64 TMP SMX 64 EDSS scores 64 renal cell carcinomas 64 ZOLINZA 64 LEXIVA r 64 Cimzia TM 64 advanced hepatocellular carcinoma 64 HBeAg seroconversion 64 Natalizumab 64 cinacalcet 64 timepoints 64 lopinavir r arm 64 RE LY ® 64 complete cytogenetic response 64 plus methotrexate 64 hypercholesterolaemia 64 IPL# 64 PENTASA 64 cisplatin chemotherapy 64 briakinumab 64 Serious adverse reactions 64 splenectomized 64 fluvastatin 64 candidemia 64 rFVIIa 64 Elitek 64 non squamous NSCLC 64 hypercalcemia 64 HBeAg negative 64 GAMMAGARD 64 NOMID 64 PASI scores 64 primary immunodeficiency PI 64 Betaferon R 64 immune thrombocytopenic purpura ITP 64 IFN beta 64 salmeterol fluticasone 64 Tavocept 64 #mg doses [002] 64 decompensated liver disease 64 advanced adenomas 64 SCIg 64 chlorambucil 64 invasive candidiasis 64 Zavesca ® 64 bezafibrate 64 rosuvastatin #mg 64 MGd 64 oral Hycamtin 64 HeFH 64 tacrolimus ointment 64 PREZISTA r arm 64 virus HCV infection 64 SJIA 64 Investigational Treatment 64 mcg albinterferon alfa 2b 64 generalized edema 64 transaminase elevations 64 abacavir Ziagen 64 ara C 64 AAT deficiency 64 Doxil ® 64 receiving prophylactic anticoagulation 64 venlafaxine XR 64 CLL SLL 64 symptomatic BPH 64 INC# 64 ibandronate 64 fluticasone salmeterol 64 HBV infections 64 interferon beta therapy 64 Amrubicin 64 zileuton 64 macrolide antibiotic 64 serum calcium levels 64 tocilizumab 64 Laquinimod 64 ULORIC 64 chronic hepatitis B. 64 REYATAZ r arm 64 REMICADE ® 64 autoimmune thyroid 64 huC# DM4 64 ADHF 63 Angioedema 63 HBeAg positive 63 sJIA 63 Rebif ® 63 Acute Myeloid Leukaemia AML 63 AVONEX ® 63 levetiracetam 63 desvenlafaxine succinate 63 adult chronic ITP 63 VaD 63 weekly intravenous infusions 63 mCRC acneform rash 63 NNT = 63 biologic DMARD 63 lomitapide 63 comparator arm 63 malignant pleural mesothelioma 63 INSPIRE Trial Phase III 63 follicular lymphomas 63 highly emetogenic 63 Octreolin 63 COPD exacerbation 63 Mitoxantrone 63 blood phenylalanine Phe 63 overt nephropathy 63 aldosterone antagonist 63 TTF Therapy 63 interferon gamma 1b 63 QTc prolongation 63 virologic breakthrough 63 VELCADE melphalan 63 metastatic bladder 63 Tarceva TM 63 Lialda 63 Abilify aripiprazole 63 HBeAg negative patients 63 esophageal candidiasis 63 pyrexia mucositis sepsis febrile 63 MIRAPEX 63 hematologic toxicity 63 Myelodysplastic Syndrome MDS 63 baseline HbA1c 63 Engerix B 63 dapagliflozin plus 63 Diabetic Macular Edema 63 PegIFN RBV 63 poor metabolizers 63 INFERGEN 63 prucalopride 63 interferon alfa 63 neoadjuvant radiation 63 achieved CCyR 63 S. aureus isolates 63 hemorrhagic cystitis 63 CRVO 63 Raptiva r 63 thrombocytopenic 63 Afatinib 63 Golimumab 63 steroid dexamethasone 63 elevated LDH 63 quetiapine fumarate 63 Diabetic Neuropathy 63 postmenopausal osteoporotic women 63 Alemtuzumab 63 Squamous 63 posaconazole 63 NeuroStar TMS Therapy 63 baminercept 63 TAXOTERE ® 63 gross hematuria 63 GSK# [001] 63 tolvaptan 63 ZACTIMA 63 INTEGRILIN R 63 vWD 63 rizatriptan 63 chronic HBV 63 evaluating tivozanib 63 mg BID dose 63 moderately emetogenic 63 partial onset seizures 63 sargramostim 63 TEAEs 63 oseltamivir Tamiflu ® 63 Genentech Rituxan 63 CYT# potent vascular disrupting 63 nonmelanoma skin cancers 63 Hepatocellular Carcinoma HCC 63 venous blood clots 63 homozygous familial hypercholesterolemia 63 relapsed leukemia 63 histologically confirmed 63 CP CPPS 63 TMC# r 63 proliferative diabetic retinopathy 63 plasma kallikrein inhibitor 63 biochemical relapse 63 HCV infections 63 dosing cohort 63 pyridostigmine 63 PRADAXA 63 glycated hemoglobin levels 63 PD LID 63 aprepitant 63 SNT MC# 63 smoldering myeloma 63 posterior uveitis 63 oropharyngeal candidiasis 63 chronic ITP patients 63 mcg kg REBETOL 63 mg kg dose 63 low dose cytarabine 63 PROCRIT ® 63 tenofovir emtricitabine 63 rasagiline tablets 63 STELARA ™ 63 Seliciclib 63 chronic angina 63 quetiapine Seroquel 63 proliferative retinopathy 63 TMS Therapy 63 cutaneous squamous cell carcinoma 63 chronic hepatitis cirrhosis 63 FIRMAGON 63 eritoran 63 Viread Emtriva 63 Serdolect ® 63 beta 1a 63 intracranial hemorrhage ICH 63 decitabine 63 brivaracetam 63 lumiliximab 63 recurrent NSCLC 63 Chronic lymphocytic leukemia 63 inhaled corticosteroid ICS 62 Pulmonary Arterial Hypertension PAH 62 serum urate levels 62 mg administered orally 62 phase III isavuconazole 62 squamous histology 62 mycophenolate mofetil 62 Glypromate 62 MACUGEN 62 abacavir lamivudine 62 deep venous thromboses 62 thromboembolic events 62 heterozygous FH 62 Cethromycin 62 immunocompetent patients 62 placebo controlled clinical 62 pitavastatin 62 serum aminotransferase levels 62 CMV infection 62 constipation OIC 62 neutropenic patients 62 macroalbuminuria 62 seropositive patients 62 GRN# 62 imipenem 62 monoinfected patients 62 SEROQUEL R 62 vincristine doxorubicin 62 metastatic CRC 62 relapsing MS 62 Exacerbations 62 aldosterone antagonists 62 flutamide 62 EGFRIs 62 vidofludimus 62 Tumors shrank 62 GW# [003] 62 AGILECT ® 62 #mg BID [001] 62 herpetic keratitis 62 KRAS mutant tumors 62 relapsed multiple myeloma 62 dacarbazine DTIC 62 treatment naive genotype 62 Myelodysplastic syndromes MDS 62 adalimumab 62 receiving INTRON 62 golimumab CNTO 62 INVEGA ® 62 Cariprazine 62 advanced adenoma 62 LY# [003] 62 metformin HCl 62 Folfox 62 AML MDS 62 acute GvHD 62 oral antidiabetic medication 62 invasive aspergillosis 62 BENICAR HCT 62 alfa 2a 62 Pegasys ® 62 malignant neoplasm 62 Intravenous immunoglobulin 62 clinically meaningful improvements 62 haloperidol Haldol 62 plus dexamethasone 62 Navelbine 62 CIN3 62 thetreatment 62 gemcitabine cisplatin 62 AZT zidovudine Retrovir 62 histologic subtype 62 DOXIL 62 mycophenolate mofetil MMF 62 haematologic 62 Ozurdex 62 Navelbine ® 62 antiretroviral naive 62 inhibitor RG# 62 pimecrolimus 62 AGHD 62 standard chemotherapy regimen 62 ziconotide 62 HoFH 62 peritumoral brain edema 62 ertapenem 62 refractory anaplastic astrocytoma 62 MabThera Rituxan 62 ELND# 62 pCR 62 mcg QD 62 endometrial hyperplasia 62 invasive fungal infection 62 metastatic neuroendocrine tumors 62 BoNTA 62 solifenacin 62 receiving XGEVA 62 salmeterol fluticasone propionate 62 DAS# CRP 62 elotuzumab 62 beclomethasone dipropionate 62 abiraterone acetate 62 XIENCE V PROMUS Stent 62 FluCAM 62 inflammatory acne 62 dopamine partial agonist 62 RSV hospitalizations 62 receiving golimumab 62 basal bolus regimen 62 tiotropium bromide 62 K ras mutations 62 severe hypersensitivity reactions 62 anti EGFR antibody 62 NATRECOR ® 62 LANTUS ® 62 post herpetic neuralgia PHN 62 immunomodulatory agents 62 Severe Primary IGFD 62 dermatologic reactions 62 weekly CSBMs 62 OHR/AVR# 62 hepatitis C genotype 62 Tolvaptan 62 gastrin analogue TT 62 RSV infection 62 ARIXTRA 62 differentiated thyroid 62 rilonacept 62 bone marrow reticulin deposition 62 romiplostim 62 Darusentan 62 iniparib BSI 62 mepolizumab 62 HuMax EGFr 62 Increlex ® 62 VAPRISOL 62 bacterial prostatitis 62 mg/m2 dose 62 microbiological eradication 62 omega interferon 62 PAOD 62 CAMMS# 62 precancerous cervical lesions 62 progressive PsA 62 aclidinium 62 TYSABRI therapy 62 Flu Cy 62 AEGR 62 HER2 expression 62 ziprasidone Geodon 62 Aclidinium 62 idiopathic thrombocytopenic purpura 62 FASLODEX 62 relapsed SCLC 62 Pyridorin TM 62 ACR# responses 62 recurrent VTE 62 Etanercept 62 antibody MAb 62 hypereosinophilic syndrome 62 venlafaxine Effexor 62 Chronic Myelogenous Leukemia CML 62 nonvertebral fractures 62 #mg/day [001] 62 basiliximab 62 relapsing multiple sclerosis 62 pemphigus vulgaris 62 Primary IGFD 62 alvimopan 62 Mg Usa 62 dose escalation phase 62 Alkeran 62 Azilect ® 62 acute gout flares 62 Xanafide 62 Hepatotoxicity 62 HQK 62 myelodysplastic myeloproliferative diseases 62 locoregional recurrence 62 T1DM 62 STELARA 62 IFN alfa 62 arterial thromboembolic events 62 rheumatoid arthritis osteoarthritis ankylosing 62 leukemia ALL 62 Lubiprostone 62 #I TM# 62 COPAXONE ® 62 relapsing remitting MS RRMS 62 fingolimod 62 PREZISTA rtv 62 Raptiva R 62 skeletal metastases 62 oral rivaroxaban 62 Relapsing remitting MS 62 chronic HBV infection 62 β blockers 62 patients undergoing CABG 62 methotrexate monotherapy 62 goserelin 62 mcg BID 62 Syncria 62 Interferon beta 1b 62 LIALDA 62 antiepileptic drug 62 latent celiac disease 62 galiximab 62 HBeAg 62 HGPIN 62 MGUS 62 ToGA 62 Daclizumab 62 cardiac toxicity 62 pegylated liposomal doxorubicin 62 nephrotoxicity 62 idraparinux 62 mcg Albuferon 62 LEUKINE 62 INCB# [001] 62 pimecrolimus cream 62 doripenem 62 Bronchiectasis 61 ischemic cardiomyopathy 61 relapsed CLL 61 Vandetanib 61 symptomatic paroxysmal AF 61 mCRC patients 61 infliximab monotherapy 61 Cipralex ® 61 metastatic malignant 61 Vaprisol 61 malignant neoplasms 61 alpha interferons 61 ALT elevation 61 tegaserod 61 angiographic outcomes 61 carotid stenosis 61 PsA 61 LymphoStat B belimumab 61 placebo controlled clinical trials 61 osteoporotic vertebral compression fractures 61 HBeAg + 61 ancrod 61 Fibrillex TM 61 undergone radical prostatectomy 61 thromboembolic 61 ZYVOX 61 carcinoid tumors 61 inhaled corticosteroid therapy 61 intravitreal insert 61 Telintra 61 Telithromycin 61 oxcarbazepine 61 ACR# response 61 docetaxel Taxotere ® 61 patients evaluable 61 aripiprazole Abilify 61 Adalimumab 61 AVODART 61 FAMPYRA 61 heavily pretreated 61 plaque psoriasis 61 Hepsera adefovir dipivoxil 61 acute leukemias 61 relapsed myeloma 61 secondary hyperparathyroidism 61 mesalamine granules 61 Toxicities 61 leukotriene receptor antagonists 61 nucleotide analogue 61 Pegasys peginterferon alfa 2a 61 Remicade infliximab 61 NVA# 61 unresectable tumors 61 refractory CLL 61 hypophosphatemia 61 relapsed ALL 61 EFFEXOR XR 61 ritonavir boosted atazanavir 61 severe asthma exacerbations 61 calcineurin inhibitors 61 Cancidas 61 partial remissions 61 SOM# 61 Rheumatoid Arthritis RA 61 Certolizumab pegol 61 clobazam 61 Non inferiority 61 overactive bladder symptoms 61 sorafenib tablets 61 Femara letrozole 61 Aptivus ® 61 neurologic complications 61 dalfampridine 61 hyperoxaluria 61 PRADAXA #mg 61 metastatic lung cancer 61 rufinamide 61 reflux disease GERD 61 LymphoStat B 61 Neupro R 61 peginterferon alfa 2a 61 gastrointestinal GI motility disorders 61 #mg dose [003] 61 Pharmacokinetic parameters 61 probiotic supplementation 61 debilitating complication 61 administered subcutaneously 61 oxymorphone ER 61 PSVT 61 ADPKD 61 exocrine pancreatic insufficiency EPI 61 stage IIIB IV 61 dexamethasone intravitreal implant 61 pioglitazone hydrochloride 61 peginterferon alpha 2a 61 lanthanum carbonate 61 entecavir 61 Ribavirin causes 61 E1 INT TM 61 Hypotension 61 PNH patients 61 baseline LDH 61 complete remissions 61 pomalidomide 61 budesonide foam 61 Chronic Idiopathic Constipation 61 oxypurinol 61 plus OBT 61 thyrotropin levels 61 neuroendocrine cancers 61 overactive bladder syndrome 61 ritonavir boosted protease inhibitor 61 protease inhibitor PI 61 serum HCV RNA 61 gastrointestinal perforation 61 urate lowering therapy 61 clozapine Clozaril 61 CVD mortality 61 nondiabetic patients 61 artery stenosis 61 MabCampath 61 ritonavir boosted 61 VFEND 61 efaproxiral 61 lupus erythematosus 61 lenalidomide dexamethasone 61 novel VDA molecule 61 diabetic macular edema DME 61 CIN2 + 61 bardoxolone methyl 61 symptomatic VTE 61 systemic corticosteroid 61 Allovectin 7 ® 61 comorbid psychiatric 61 tinidazole 61 LHRH agonists 61 tapentadol ER 61 non hematological toxicities 61 annualized relapse 61 myeloproliferative diseases 61 clinically meaningful efficacy 61 gastrointestinal stromal tumors GIST 61 neutropaenia 61 Dasatinib 61 #mg dose [001] 61 Pegasys plus Copegus 61 5-FU/LV 61 immune thrombocytopenic purpura 61 recurrent venous thromboembolism 61 prolonged QT interval 61 elevated LDL cholesterol 61 chronic periodontitis 61 AVANDIA 61 primary hypercholesterolemia 61 hormone refractory metastatic prostate 61 PROCHYMAL 61 retinal vein occlusion 61 RSD# oral 61 basal cell nevus syndrome 61 anagrelide 61 onset atrial fibrillation 61 PPAR gamma agonist 61 unstable angina pectoris 61 QVA# 61 symptomatic intracranial 61 juvenile idiopathic arthritis JIA 61 KRAS status 61 TAXUS Stent 61 prior chemotherapy regimens 61 chronic thromboembolic pulmonary 61 metastatic renal 61 betamethasone dipropionate #.# 61 brimonidine 61 ® lenalidomide 61 C1 INH deficiency 61 Platinol ® 61 Serious Adverse Events 61 interferon alfa 2b 61 demonstrated antitumor activity 61 recurrent metastatic 61 selective phosphodiesterase 61 FOLFIRI alone 61 Fingolimod 61 tipranavir ritonavir 61 regorafenib 61 clevidipine 61 SUPPRELIN R LA 61 seroconverted 61 basal cell carcinoma BCC 61 nonsmall cell lung cancer 61 Pharmacokinetics PK 61 retinal vein occlusion induced 61 Tamibarotene 61 mL/min/#.# m 2 61 cutaneous melanoma 61 plus gemcitabine 61 Zarnestra 61 benazepril 61 doxazosin 61 stable angina 61 metastatic gastric 61 BRIM2 61 metastatic carcinoid tumors 61 pouchitis 61 Moxifloxacin 61 receiving highly emetogenic 61 salmeterol HFA MDI 61 antiepileptic medications 61 depsipeptide 61 glucocorticoid induced osteoporosis 61 TTR amyloidosis 61 Gemzar ® 61 chronic immune thrombocytopenic 61 micafungin 61 gastric adenocarcinoma 61 AMEVIVE 61 undetectable viral 61 microscopic hematuria 61 rheumatoid arthritis psoriatic arthritis 61 achieved PASI 61 systemic lupus erythematosus SLE 61 TYGACIL 61 rindopepimut 61 infliximab Remicade 61 Heavy menstrual bleeding 61 alanine aminotransferase ALT 61 thalidomide Thalomid 61 cytopenias 61 Reverset 61 Proellex TM 61 cIAI 61 IGFD 61 ACTEMRA 61 efavirenz Sustiva 61 Allergic Rhinitis 61 atazanavir ritonavir 61 placebo PBO 61 Hycamtin ® 61 metastatic RCC 61 Juvenile Idiopathic Arthritis 61 Atomoxetine 61 Genasense ® 61 metoprolol tartrate 61 Azedra 61 IBS C 61 lenalidomide Revlimid R 61 Renal Cell Carcinoma RCC 61 ribavirin therapy 61 leucopenia 61 DEB# 61 amoxicillin clavulanate 61 anthracycline taxane 61 ARCALYST 61 synthetic retinoid 61 EOquin TM 61 gemifloxacin 61 severe renal impairment 61 extrapyramidal symptoms 61 Fludara 61 cytogenetic responses 61 underwent surgical resection 61 APTIVUS ritonavir 61 lupus nephritis 61 RhuDex R 61 Welchol 61 Neovascular Age Related Macular 61 metastatic renal cell 61 metformin hydrochloride 61 Arcalyst 60 Safinamide 60 sunitinib malate 60 dalteparin 60 Tesmilifene 60 severe gastroparesis 60 gadobutrol 60 discontinued Viread 60 brand ciclesonide HFA 60 Durezol 60 STRIDE PD 60 metaglidasen 60 Maribavir 60 Renal impairment 60 euvolemic 60 Major Depressive Disorder 60 abnormal lipid 60 paricalcitol 60 TNF Tumor Necrosis Factor 60 SGPT 60 Crohn Disease Activity 60 antidiabetic drug 60 pegylated interferon alpha 60 Plicera 60 Tiotropium 60 lipid lowering agents 60 heavily pretreated patients 60 CMV disease 60 tarenflurbil 60 DPNP 60 episodic migraine 60 PEGINTRON TM 60 endoscopic remission 60 Tarceva erlotinib 60 receiving immunosuppressive therapy 60 ciclesonide 60 divalproex sodium 60 Parathyroid Hormone 60 β blocker 60 CLARITY study 60 dual endothelin receptor antagonist 60 recurrent glioma 60 MIRAPEX ER 60 headache nasopharyngitis 60 cilostazol 60 CCyR 60 GnRH agonists 60 Ceplene/IL-2 60 treatment naïve genotype 60 Decitabine 60 mertansine 60 Rilonacept 60 interferon ribavirin 60 docetaxel chemotherapy 60 ano genital warts 60 nitrofurantoin 60 NLX P# 60 protease inhibitors PIs 60 ulcerative colitis UC 60 tamoxifen Nolvadex ® 60 PRTX 60 pericardial effusion 60 PEGylated interferon beta 1a 60 ARIMIDEX 60 ß blockers 60 perampanel 60 interferon beta 1b 60 intravitreal injections 60 oral olanzapine 60 docetaxel Taxotere 60 HER2 overexpression 60 neurodevelopmental impairment 60 relapsing remitting 60 thromboembolic complications 60 Sanofi Aventis Taxotere 60 oral diclofenac 60 cabazitaxel 60 tolerability profiles 60 Avandia Actos 60 seropositivity 60 huN# DM1 60 renal toxicity 60 HuMax CD4 60 HER2 positive cancers 60 CIMZIA R 60 Liprotamase 60 inhalation powder 60 clazosentan 60 antiemetics 60 AmBisome 60 morphometric vertebral fractures 60 nucleotide analog 60 candidiasis 60 T2 lesion volume 60 acute HAE attacks 60 unresectable stage 60 venous stasis ulcers 60 antiretroviral naïve 60 dose cohorts 60 HIV coinfected 60 IXEMPRA 60 de aths 60 inhaled iloprost 60 acetylcholinesterase inhibitor 60 R# #mg BID 60 gastrointestinal stromal tumor GIST 60 anthracyclines taxanes 60 HIV uninfected 60 nadroparin 60 AZILECT 60 squamous cell lung cancer 60 etanercept 60 Paxil paroxetine 60 leukopenia 60 recurrent glioblastoma 60 hematological adverse 60 null responder 60 Zavesca R 60 terlipressin 60 diabetic kidney 60 favorable pharmacokinetic profile 60 #OHD levels 60 balsalazide 60 paroxetine Paxil 60 Interferon alpha 60 crizotinib PF # 60 Betaferon ® 60 anti angiogenic therapy 60 nalbuphine ER 60 genotypic resistance 60 TNF antagonists 60 untreated metastatic colorectal 60 PegIntron 60 recurrent GBM 60 PRECiSE 60 Urea Cycle Disorder 60 opioid induced constipation OIC 60 tumor lysis syndrome 60 6R BH4 60 painful diabetic neuropathy 60 Forodesine HCl 60 alkylating agent 60 APTIVUS 60 Victoza R 60 euvolemic hyponatremia 60 Gastrointestinal GI 60 superficial basal cell carcinoma 60 heFH 60 SUTENT 60 RLAI 60 overactive bladder OAB 60 pseudobulbar affect PBA 60 Idiopathic Pulmonary Fibrosis 60 preoperative chemotherapy 60 external genital lesions 60 moderate renal impairment 60 Cimzia R 60 DEFLUX 60 Alequel 60 hepatocellular carcinomas 60 oral vancomycin 60 Omacetaxine 60 del 5q MDS 60 Celsentri Selzentry 60 zolmitriptan 60 HCV RESPOND 2